Restructuring Body Experience in Anorexia Nervosa: Virtual Reality Functionality-Focused Mirror Exposure

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age16+
SponsorCatholic University of the Sacred Heart

About this trial

Background: Body image disturbance remains a core therapeutic challenge in Anorexia Nervosa (AN) treatment, necessitating innovative intervention approaches. This study protocol describes a randomized controlled trial investigating Virtual Reality Functionality-Focused Mirror Exposure (VR-FME), a novel intervention targeting the perceptual, affective, and cognitive dimensions of body image disturbance in AN patients.

Methods: This single-blind, parallel-group randomized controlled trial will evaluate the efficacy of VR-FME as an adjunct to treatment as usual (TAU). Participants with AN will be randomly allocated to receive either VR-FME combined with TAU or TAU alone. The intervention specifically addresses altered body image through immersive virtual reality technology, providing controlled exposure and cognitive restructuring opportunities.

Primary Outcome: The primary outcome measure will assess changes in body image disturbance severity and core eating disorder symptomatology. We hypothesize that the integration of VR-FME with TAU will demonstrate superior therapeutic outcomes compared to TAU alone.

Significance: This protocol represents an innovative approach to addressing body image disturbance in AN, potentially enhancing current therapeutic strategies through the integration of immersive virtual reality technology. The findings will contribute to the evolving landscape of technology-enhanced interventions for eating disorders.

Eligibility criteria

Qualifiers

Age: between 16-24.

Primary diagnosis of Anorexia Nervosa

BMI > 14.5

No current diagnosis or previous diagnosis for neurological disorders

Disqualifiers

Anorexia Nervosa is not a primary diagnosis

Age < 16

BMI < 14.5

Conditions that could interfere with VR use (e.g., neurological conditions, severe visual impairments, vestibular disorders)

Trial design

Treatments tested in this trial

  • VR -FME

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Catholic University of the Sacred Heart

Lead sponsor

Fatebenefratelli Hospital

Collaborator

Centro ABA Fatebenefratelli

Collaborator